1 / 31

FY1 Calcium/Phosphate/ Magnesium Homeostasis

FY1 Calcium/Phosphate/ Magnesium Homeostasis. Funmi Awopetu Senior Clinical Scientist King George Hospital. Ca/P/Mg. Intro Calcium Phosphate Magnesium Investigations. Calcium. 99% present in skeleton (reservoir) Serum calcium 2.15-2.6 mmol/L Functions of calcium

Rita
Download Presentation

FY1 Calcium/Phosphate/ Magnesium Homeostasis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. FY1 Calcium/Phosphate/ Magnesium Homeostasis Funmi Awopetu Senior Clinical Scientist King George Hospital

  2. Ca/P/Mg • Intro • Calcium • Phosphate • Magnesium • Investigations

  3. Calcium • 99% present in skeleton (reservoir) • Serum calcium 2.15-2.6 mmol/L • Functions of calcium • Intracellular signalling • Coagulation • Bone mineralization • Plasma membrane potential

  4. Calcium Homeostasis Parathyroid gland Skeleton Intestine Ca++ Vitamin D Kidneys

  5. Calcium Metabolism • Forms • Free – 50% • Bound – protein – 40% • Complexed – 10% • Hence adjusted for albumin • Acid base status • Calcium sensing receptor • PTH • Vitamin D • (calcitonin)

  6. Adjusted Calcium Total Ca + ((44-Alb) x 0.015) • Advantages • Accounts for changes in alb conc • To calculate the expected Ca conc if the alb were normal • Limitations • Interpret with caution when H+ status abnormal • Not valid when alb very low eg <20

  7. Errors in Calcium measurement • In Vitro • Inappropriate anticoagulants • Dilution with liquid heparin • Contamination with calcium • Spectrophotometric interference In vivo • Tourniquet use and venous occlusion • Changes in posture • Exercise • Hyperventilation • Alterations in protein binding / complex formation

  8. PTH • 84 aa • Synthesised by parathyroid gland • Bio activity in aa 1-34 (fragments) • Intact PTH T1/2 3-4 mins • Inhibited by • Hypercalcaemia (secretion) • 1,25D (synthesis) • Normal levels 1.3 – 6.8 pmol/L

  9. PTH • Bone resorption – to release Ca/P • Rapid release and longer term response – proliferation of osteoclasts • Kidney • distal tubule reabs of calcium (hypercalciuria) • Phosphaturia inhibits P reabs from prox tubule • Calcitriol ( intestine)

  10. Vitamin D • Diet/UV sunlight (D2/D3) • 25 hydroxy D (liver) • 1,25 dihydroxy Vitamin D (kidney) – tightly regulated • Active form 1,25VitD • VitD action • Absorption of phosphate and calcium from intestine • PTH • 25OHD best measure – reflects sun and diet, long T1/2

  11. Hypercalcaemia • Increased flux of Ca2+ into the ECF from skeleton, kidney or intestine • Lethargy • Nausea • Vomiting • Bones, moans, groans and stones • Polyuria • Symptoms dependent on rate of increase

  12. Causes of Hypercalcaemia • Contamination • Primary hyperparathyroidism • Malignancy (skeletal involvement/PTHRP) • Endocrine disorders – hyper-/hypothyroidism/acute adrenal insufficiency • FHH 95% • Renal failure • Idiopathic hyperCa of infancy • Granulomatous disorders (eg sarcoidosis and TB) • Chlorthiazide diuretics • Lithium • Milk alkali syndrome • etc

  13. Hyperparathyroidism • PTH Inappropriate to calcium level • Raised calcium with raised/normal PTH • ? Primary • ?Secondary/Tertiary • Primary - usually due to parathyroid adenoma (single/multiple) • Multiple - ? MEN • Treatment • High fluid intake • Surgery • Watch and wait • Side effects • Osteoporosis • Renal failure • Stones

  14. FHH • Familial hypocalciuric hypercalcaemia • Autosomal dominant mutation in calcium sensing receptor  increased set point for calcium • Asymptomatic hypercalcaemia • Normal/slightly elevated PTH • Must differentiate from primary hyperparathyroidism • Low rate of calcium excretion in urine

  15. Investigations • Bone profile • Renal function • PTH (>3 pmol/L inappropriate for hyperCa) • ? Primary HyperPTH or FHH • Urinary fractional calcium excretion • Fasting urine calcium x serum creatinine Urine creatinine < 25 umol/L FHH > 30 umol/L PHPT

  16. Case • 51 year old woman investigated after ureteric colic shown on radiological examination to be due to Ca containing calculi. • Serum Calcium 2.95 mmol/L • Phosphate 0.7 mmol/L • PTH 10 pmol/L • Bone radiographs normal • Serum urea, albumin ALP normal

  17. Hypocalcaemia • Symptoms • Chvosteks and Trousseau’s signs • Neuromuscular excitability • Tetany • Paresthesia • Seizures

  18. Causes of hypocalcaemia • Contamination • Hypoalbuminaemia • Chronic renal failure • Magnesium deficiency • Hypoparathyroidism (/pseudo) • Vitamin D deficiency (or resistance) • Acute haemorrhagic and edematous pancreatitis • Hungry bone syndrome

  19. Chronic Renal failure • Phosphate • Protein • 1, 25 Vit D • Skeletal resistance to Vitamin D

  20. Investigations • Bone profile • Renal function • Mg • Vitamin D • ? History (eg surgery to neck) • ? PTH

  21. Phosphate Metabolism • 85% present in skeleton • Serum inorganic phosphate 0.84-1.45 mmol/L • 10% protein bound, 35% complexed, rest free • Integrity of bone • Oxygen delivery • Muscle contraction • Role in ATP (energy), nucleotides, NADP, cell membranes, gene transcription, cell growth • Balance maintained primarily by kidneys

  22. Hyperphosphataemia Decreased renal excretion • GFR • Reabsorption • hypoPTH • Acromegaly • Disodium etidronate • Cell Lysis • Rhabdomyolysis • Intravascular haemolysis • Cytotoxic therapy • Leukaemia • Lymphoma • Increased intake • Oral or IV • P containing laxatives/enemas • Vit D intoxication • Transcellular shift • Lactic acidosis • Respiratory acidosis • DKA

  23. Hyperphosphataemia • Exclude spurious • delayed sample receipt • haemolysis (HM2) • anticoagulants EDTA/citrate – interfere with complex formation during analysis

  24. Hypophosphataemia • Common • Muscle weakness • Respiratory failure • Decreased myocardial output • Rhabdomyolysis < 0.15mmol/L • Severe hypoP  haemolysis • Rickets/osteomalacia (chronic defy) • Wernicke’s encephalopathy

  25. Hypophosphataemia • Decreased absorption • Increased loss • Vomiting • Diarrhoea • Phosphate binding antacids • Decreased absorption • Malabsorption syndrome • VitD defy • Poor diet Intracellular shift • Glucose • Insulin • Resp alkalosis • Refeeding • Lowered renal P threshold • Primary hyperPTH • Renal tubular defects • Familial hypophospataemia • Fanconi’s

  26. Investigations • ? History • ? Contamination ? Repeat • Bone profile • Renal function • Mg • ? Vitamin D (?Ca) • ? PTH (?Ca)

  27. Magnesium Metabolism • 55% present in skeleton • 1% of total body Mg extracellular • Serum Mg 0.7-1.0 mmol/L • Cofactor for enzymes • Required for ATP (MgATP) • Glycolysis • Cell replication • Protein biosynthesis • PTH increases renal tubular reabs of Mg • Homeostasis maintained - control of excretion

  28. Hypermagnesaemia Symptoms • Depressed neuromuscular system • Depressed respiration • Cardiac arrest Causes • Excessive intake • Antacids • Enemas • Parenteral therapy • Mg administration (RF)

  29. Hypomagnesaemia • Common in inpatients • Usu assoc with hypoK and hypoP • Increased neuromuscular excitability • Causes impaired PTH secretion • PTH end organ resistance • Oral K not retained if patient also Mg deficient • Assoc. with Ca defy with overlapping symptoms • HypoCa and HypoK unresponsive to supplementation should prompt Mg measurement

  30. Hypomagnesaemia • GI • Prolonged nasogastric suction • Malabsorption • Bowel resection • Diarrhoea • Fistulas • Acute pancreatitis • Decreased intake • Chronic vomiting • Redistribution • DKA • Hungry bone disease • Renal loss • Chronic TPN • Osmotic diuresis (DM/mannitol) • Hypercalcaemia • Alcohol • Drugs – diuretics/aminoglycosides/cisplatin/cardiac glycosides • Metabolic acidosis (DKA/ETOH/starvation) • Renal disease

  31. Questions?

More Related